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ORIGINAL RESEARCH COMMUNICATION
Conformational Change of Mitochondrial Complex I
Increases ROS Sensitivity During Ischemia
Natalia Gorenkova,1 Emma Robinson,2 David J. Grieve,2 and Alexander Galkin1
Abstract
Aims: Myocardial ischemia/reperfusion (I/R) is associated with mitochondrial dysfunction and subsequent
cardiomyocyte death. The generation of excessive quantities of reactive oxygen species (ROS) and resultant
damage to mitochondrial enzymes is considered an important mechanism underlying reperfusion injury. Mi-
tochondrial complex I can exist in two interconvertible states: active (A) and deactive or dormant (D). We have
studied the active/deactive (A/D) equilibrium in several tissues under ischemic conditions in vivo and inves-
tigated the sensitivity of both forms of the heart enzyme to ROS. Results: We found that in the heart, t½ of
complex I deactivation during ischemia was 10 min, and that reperfusion resulted in the return of A/D equi-
librium to its initial level. The rate of superoxide generation by complex I was higher in ischemic samples where
content of the D-form was higher. Only the D-form was susceptible to inhibition by H2O2 or superoxide, whereas
turnover-dependent activation of the enzyme resulted in formation of the A-form, which was much less sensitive
to ROS. The mitochondrial-encoded subunit ND3, most likely responsible for the sensitivity of the D-form to
ROS, was identified by redox difference gel electrophoresis. Innovation: A combined in vivo and biochemical
approach suggests that sensitivity of the mitochondrial system to ROS during myocardial I/R can be signifi-
cantly affected by the conformational state of complex I, which may therefore represent a new therapeutic target
in this setting. Conclusion: The presented data suggest that transition of complex I into the D-form in the absence
of oxygen may represent a key event in promoting cardiac injury during I/R.
Introduction
The effects of a reduction in the oxygen level involves arapid response from the mitochondrial system as this is
the major consumer of oxygen in a cell. Hypoxia can be fol-
lowed by recovery of the oxygen supply (reoxygenation),
which augments tissue damage. Ischemia/reperfusion (I/R)
injury and its therapeutic reduction have become increasingly
important issues in clinical medicine. It is well established that
cardiac ischemia leads to a decline in the activity of several
mitochondrial components, which is intensified by reperfu-
sion. This results in myocardial dysfunction, most likely due
to the production of excessive quantities of reactive oxygen
species (ROS), which is considered as one of the major
mechanisms underlying I/R injury (3, 5, 28, 38, 51).
Mitochondrial complex I (EC 1.6.5.3) oxidizes NADH,
contributing to the formation of membrane potential and
consequently ATP synthesis, and therefore occupies a key
position in cellular metabolism. Complex I is also an impor-
tant source of superoxide and, most likely, it is responsible for
the majority of ROS produced by the respiratory chain in vivo
(10, 33). Mitochondrial complex I responds rapidly to lack of
Innovation
Mitochondrial function is altered during hypoxia and
following reoxygenation. We report here that sensitivity of
the mitochondrial complex I to oxidative assault during
ischemia/reperfusion could be determined by the confor-
mational state of complex I. Transition of complex I into the
dormant form in the absence of oxygen may make an im-
portant contribution to irreversible tissue damage during
postischemic reoxygenation and may therefore represent a
novel therapeutic target in this setting.
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oxygen and is damaged by subsequent reoxygenation (5, 24,
34, 37, 45). The altered activity of complex I can have a sig-
nificant effect on mitochondrial ROS generation. Moreover,
this enzyme is not only a major source of ROS, but is also
susceptible to damage during I/R, including that caused by
oxidative and nitrosative stress (6, 12, 51).
Reversible conversion of the active, A-form of complex I
into the dormant, D-form has been described in vitro (31), in
rat heart ex vivo (39), and recently, in studies of cultured cells
(14). If idle at physiological temperatures, the enzyme un-
dergoes conversion into the D-form, which is characterized
by a 10,000-fold lower catalytic activity compared to the
catalytically competent A-form (53). In contrast to irrevers-
ibly inactive enzyme, the D-form is potentially capable of
catalyzing a fast reaction and can be converted to the A-form
after slow catalytic turnover(s) when substrates become
available. Despite recent progress made in the resolution of
the bacterial enzyme (9), very little is known about the eu-
karyotic complex I, so it is not yet possible to suggest the
nature of the gross structural changes in the enzyme during
activation/deactivation.
Deactivation of the enzyme in the absence of oxygen (14,
39) is an intrinsic property of complex I and it would be ex-
pected to play a functional role. However, in the time frame of
ischemic conditioning, prolonged accumulation of the D-form
may have severe pathophysiological consequences, depend-
ing on the duration of exposure, type of tissue, and the pres-
ence of natural effectors of the active/deactive (A/D)
transition and of the ROS/antioxidant balance.
We have previously investigated the effects of lack of
oxygen on the conformational state of mitochondria com-
plex I and its sensitivity to nitric oxide-metabolites in
isolated mitochondrial membranes and cultured cells (14,
17). Taking into account the role of complex I in generat-
ing ROS in I/R (13, 22, 42) and subsequent damage to
oxidative phosphorylation, we sought to characterize
changes in complex I states during I/R in an established
experimental model. Here we present data showing that
reversible deactivation of mitochondrial complex I takes
place in situ under ischemic conditions and report the
differential sensitivity of the two forms of the enzyme to
superoxide anion and peroxide. We found that 50% de-
activation of complex I occurs within 10 min of cardiac
arrest, while reperfusion resulted in the return of complex
I A/D equilibrium to its initial level. The D-form of
complex I isolated from the ischemic samples was found
to be sensitive to ROS treatment, and that sensitivity was
eliminated by activation. Furthermore, oxidative modifi-
cation of the D-form of the enzyme in vitro resulted in a
decrease in the rate of NADH oxidation indicating func-
tional damage of the enzyme. Subunits responsible for
functional modification of the D-form of the enzyme have
also been identified.
Results
A/D transition in vivo in different tissues
First, the effect of induced cardiac arrest on the A/D ratio of
complex I was investigated in different tissues 20 min after
cardiac arrest (Fig. 1). The greatest degree of deactivation was
observed in highly metabolizing tissues such as the heart and
brain.
Cardiac I/R and activation state of complex I
Next, reversibility of complex I deactivation was assessed
in situ. The effect of local myocardial ischemia with or without
reperfusion, on complex I-catalyzed activities and on the A/D
ratio is shown in Figure 2. There was almost twice as much
FIG. 1. Percentage (%) of the D-form of mitochondrial
complex I in different tissues determined as described in
Materials and Methods. Tissues were extracted immediately
after cardiac arrest (black bars) or 20 min later (white bars).
Each column represents mean– SEM, n= 3 animals per
group, two experiments, triplicate measurements. *p< 0.05;
**p < 0.01, compared to corresponding control samples.
FIG. 2. NADH-dependent activities of mitochondrial
complex I and quantification of D-form percentage in
mouse heart mitochondrial membranes isolated from in-
farct and control (black and white, respectively), and
ischemia/reperfusion and control samples (hatched and
dashed, respectively). Each column represents mean – SEM,
n = 7–8 animals per group, *p< 0.05.
2 GORENKOVA ET AL.
complex I in the D-form in samples from ischemic tissues as
there was in control tissues. In samples taken after reperfusion
of the ischemic area, the D-form content was similar to that in
the control samples. As judged by the NADH-oxidase and
hexaammineruthenium (III) chloride (HAR)-reductase activ-
ity, the complex I activity and content in ischemic and
reperfused samples was not different from that in the control
samples. There was no significant difference between NADH-
and succinate-supported generation of superoxide in any of
the samples (data not shown).
Time course of complex I deactivation in heart
To determine the time course of complex I deactivation after
cardiac arrest in situ, heart mitochondrial membranes were iso-
lated at different periods after cardiac arrest, taking care to
preserve the A/D ratio. The time course of myocardial complex I
deactivation after cardiac arrest is shown in Figure 3. The t1/2 of
deactivation was around 10 min. However, it should be noted
that neither the total NADH-oxidase nor cytochrome c oxidase
activity was significantly altered by ischemia.
Myocardial superoxide production by the mitochondrial
respiratory chain after cardiac arrest
The percentage of the D-form of complex I in mitochondrial
membranes obtained from mouse hearts from the control
group and 20 min after cardiac arrest was 10% and 65%, re-
spectively (Table 1). The rate of NADH-supported superoxide
generation was significantly higher in mitochondrial samples
obtained 20 min after cardiac arrest than in control samples.
Turnover-dependent activation eliminated that difference
between these samples (data not shown). Rate of succinate-
supported superoxide generation was found to be similar in
control and ischemic samples (Table 1).
Sensitivity of the A- and the D-forms
of complex I to H2O2 and O2$
-
Mitochondrial membranes isolated from heart at 0 and
20 min after cardiac arrest (containing 8% and 67% of complex
I in the D-form, respectively), were subjected to incubation for
30 min in the presence of the xanthine/xanthine oxidase su-
peroxide generating system. After addition of 50 lM xanthine,
the system is able to generate superoxide at an initial rate of
50 nmol/min/mg protein, as assessed by superoxide dis-
mutase (SOD)-sensitive reduction of acetylated cytochrome c.
As shown in Table 2, incubation of mitochondria with this
O2$
- -generating system resulted in a significant decrease in
the NADH-oxidase activity in heart tissue samples obtained
20 min after cardiac arrest. This effect was abolished when all
the D-form is converted into the A-form. Addition of 50 U/ml
catalase to the incubation medium did not alter the observed
effect, while the presence of 50 U/ml SOD completely pre-
vented the inhibitory actions of the O2$
- -generating system in
all samples. There was no significant effect on the succinate-
oxidase activity of mitochondrial membranes from either
sample.
Figure 4A demonstrates a dramatic difference in the sen-
sitivity of the A- and the D-form of complex I to hydrogen
peroxide. Incubation in the presence of 1.0 mM H2O2 led to
the inhibition of the NADH-oxidase reaction of the D-form,
but not the A-form. The time course of inhibition of
the NADH:Q1 reductase activity was similar to that of
FIG. 3. Effect of global ischemia in heart tissue. Time
course of deactivation of mitochondrial complex I in heart
tissue (A) after cardiac arrest and (B) effect on total NADH-
oxidase (white bars) and cytochrome oxidase activity (gray
bars). Percentage of the D-form and activity in samples was
determined as described in Materials and Methods. Each
column represents mean– SEM, n= 3 animals per group, two
experiments, triplicate measurements in each experiment.
Table 1. Generation of Superoxide by Myocardial
Mitochondrial Membrane Preparations from a










(nmol ·min - 1
·mg - 1)
Control 10 – 3 0.55 – 0.08 1.35 – 0.35
20 min 65 – 5b 1.02 – 0.21b 1.21 – 0.29
Values represent means of quadruplicate measurements in two
experiments.
aActivity was measured in the presence of 1 lM antimycin A.
bn = 3 animals per group, two experiments, quadruplicate mea-
surements p< 0.05 versus control.
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NADH-oxidase, indicating a direct effect on complex I. Pre-
sence of 50 U/ml SOD did not affect the time course of inac-
tivation, while 100 U/ml catalase or 1.5 mM reduced
glutathione protected the D-form of the enzyme from inacti-
vation (Fig. 4B). Careful titration of the D-form of the enzyme
in the presence of catalase inhibitor 3-amino-1,2,4-triazole
(Fig. 4C) shows the sensitivity of the D-form to H2O2.
Identification of the subunits involved in oxidative
modification of the D-form by redox difference gel
electrophoresis
Cysteine-reactive Cy3-N-ethylmaleimide (NEM) and Cy5-
NEM dyes were used to label oxidized protein thiols in the A-
or the D-form of complex I after H2O2 treatment. Blue native
PAGE followed by double SDS-gel separation of complex I
subunits allows identification of differentially labeled thiols of
complex I in H2O2-treated samples of the A- form and the D-
form without interference from other mitochondrial proteins
(Fig. 5A). Control samples without H2O2 treatment demon-
strated significantly more labeled spots with no difference in
the fluorescent signal between the A- and the D-form (not
shown). Most of the fluorescent spots had equal Cy3 and Cy5
signal so that the ratio of Cy3 and Cy5 fluorescence intensity
was between 0.8–1.2, indicating equal amount of oxidized
thiols in corresponding subunits in both samples. The total
number of fluorescent spots in H2O2-treated samples was
much less than the number of protein spots revealed by silver
staining (Fig. 5B). Reciprocal labeling experiments, where the
D-form was labeled with Cy3 and the A-form with Cy3
showed the same results, although a slight dye-dependent
shift in the electrophoretic mobility of some Cy3- and Cy5-
labeled subunits was observed. However, one spot with ap-
parent mass of 40 kDa and two spots of around 13 kDa were
significantly more labeled in the D-form than in the A-form
(Fig. 5C). Table 3 lists three complex I subunits containing
thiols with a significantly altered redox state upon H2O2
treatment of the A and the D samples identified by LC-MS/
MS under conditions listed in Supplement. In-gel digestion of
the 40-kDa spot produced only a single peptide of the mito-
chondrial ND4 subunit. However, from the unusual electro-
phoretic mobility [located at the upper diagonal (46)], it can be
concluded that this is indeed ND4. One low molecular weight
subunit was identified as B12. The highest difference in the
fluorescence intensity between the A and the D samples was
found in the third highly hydrophobic spot located above the
diagonal. The corresponding protein was expected to have
605.8 Da higher molecular mass due to Cy5-NEM labeling
(See Supplementary Data Table S1 [Supplementary Data
are available online at www.liebertpub.com/ars] for full de-
tails on LC-MS/MS analysis). Indeed, the single peptide
ANPYECGFDPTSSAR pertained to highly hydrophobic mi-
tochondrially encoded subunit ND3 having an increase in
mass corresponding to Cy5 label (+ 605.8 Da) was positively
identified in that spot. Most likely, it indicates the exact lo-
cation of cysteine residue involved in H2O2-dependent oxi-
dation and the functional loss of activity of the D-form of the
enzyme. As previously observed (16), due to the extremely
high hydrophobicity of ND3, other tryptic fragments were
unlikely to be detected. Indeed, only four potential fragments
are in the m/z range 700–5000, so low molecular weights are
not detectable and large hydrophobic peptides are barely
extractable from the 16% acrylamide gels used. Therefore, the
single identified peptide belonging to the hydrophilic region
between transmembrane helices is the only detectable peptide
from that subunit.
Discussion
I/R injury has been associated with many types of surgery
and vascular interventions. This phenomenon is particularly
relevant to cardiac operations in which reperfusion of coro-
nary flow is necessary to resuscitate the myocardium after a
period of ischemia, and to percutaneous coronary interven-
tion after myocardial infarction. If performed in a controlled
fashion and within a short time postischemia, reperfusion
may facilitate cardiomyocyte survival, reduced cardiac dam-
age, and improved post-traumatic recovery. However, the
resultant increase in ROS generation in I/R poses significant
risks and may mediate irreversible tissue damage. It is
therefore essential to understand underlying mechanisms to
inform novel therapeutic strategies to prevent I/R injury in
such clinical situations.
Two catalytically and structurally distinct forms of com-
plex I have been shown to be present in mitochondrial
membranes: one the fully competent, active A-form and the
other the dormant, deactivated, D-form.
In the present study, we performed analysis of the A/D ratio
of mitochondrial complex I from various tissues after the onset
of cardiac arrest. In the absence of oxygen, the respiratory chain
is over-reduced, resulting in the lack of second complex I sub-
strate ubiquinone, decrease of complex I catalytic turnover, and
eventual deactivation of the enzyme. In highly metabolic tissues
such as the brain and heart, 20 min of global ischemia
Table 2. Sensitivity to Superoxide of Myocardial Complex I












NADH-oxidase Control 10 – 3 0.54 – 0.14 0.56 – 0.15 2.0 – 1.1 0.51 – 0.16
20 min 65 – 5b 0.50 – 0.18 0.11 – 0.03b 4.5 – 1.4 0.45 – 0.14
Succinate oxidase Control — 0.45 – 0.05 0.43 – 0.10 — 0.45 – 0.09
20 min — 0.51 – 0.04 0.44 – 0.09 — 0.38 – 0.12
aThe heart mitochondrial fractions were diluted to 1 mg/ml with a medium containing a 50 mM phosphate buffer pH 7.2, 20 mM KCl,
0.1 mM EDTA, and components of the superoxide-generating system (50lM hypoxanthine and 5lg/ml xanthine oxidase from bovine milk).
Incubation was carried out at 20C. Superoxide dismutase 50 U/ml was used to scavenge the superoxide generated. To activate complex I,
NADPH was used as described previously (17). All activities are given in lmol substrate·min- 1 ·mg- 1.
bp< 0.05 versus control.
4 GORENKOVA ET AL.
significantly shifted the A/D equilibrium toward formation of
the D-form. This form exhibits a much lower catalytic activity
than the A-form, but unlike the irreversibly inactivated or de-
natured enzyme, the D-form can be converted to the A-form
during that slow catalytic turnover(s) and is potentially able to
catalyze a rapid physiological reaction.
To measure the full complex I activity, enzyme prepara-
tions should be activated before the measurements as carried
out in the present study and described previously (17). It is
important to stress that accumulation of the D-form during
the ischemic period observed here is fully reversible, but
could easily be mistaken for enzyme inactivation when the
NADH-oxidase activity is assessed by conventional methods.
Preparations composed of a mixture of the A- and the D-form
catalyze oxidation of NADH with a lag phase during con-
tinuous assay. This lag phase represents slow activation of the
D-fraction of the enzyme during the time of the measurement
(14) and can be easily interpreted for a linear initial rate when
an assay buffer of pH > 7.5 is used or divalent cations are
present (53). If the preparation composed mostly of the D-
form (i.e., postischemic mitochondrial samples) is assessed
without activation, the observed initial rate is low and rep-
resents only the contribution of the A-form fraction. In our
experiments, total activated NADH-oxidase did not change
with the time of ischemic treatment.
The time course of complex I deactivation in situ revealed
that the half-time (t1/2) for the heart was 12 min after the onset
of global ischemia. Using an in vivo mouse infarction model,
we showed that local cardiac ischemia results in accumulation
of the D-form, while reactivation occurs in situ after reperfu-
sion. At the same time, the D-form of complex I isolated from
the ischemic area can be reactivated in vitro during turnover-
dependent reactivation when substrates are added (14, 31, 39).
The difference in the D-form content in mitochondria derived
from the samples subjected to 20-min global ischemia ( < 60%)
and local infarction (40%) most likely reflects possible oxy-
genation of the border regions of the ischemic zone during
post-treatment surgery as well as some inaccuracy in the ex-
cision of the ischemic area of the heart.
In our I/R experiments, the complex I activity and content,
estimated from the NADH-oxidase and NADH:HAR reduc-
tase activity, was not significantly different in mitochondrial
membranes from the control and ischemic samples. A similar
oxidase/reductase rates ratio in all of the samples indicates
that neither the complex I content nor its turnover were
affected by ischemia or following reperfusion. Since the
FIG. 4. Effect of hydrogen peroxide on the A- and the D-
form of complex I. (A) NADH-oxidase activity of the A-form
(solid symbols) and the D-form (open symbols) of complex I
from heart mitochondrial membranes. (B) Effect of hydrogen
peroxide on the NADH:Q1-reductase activity of the D-form
of complex I (circles) in the presence of 50 U/ml superoxide
dismutase (triangles), 100 U/ml catalase (squares), or 1.5 mM
glutathione (diamonds). Mitochondrial membranes contain-
ing either the A- or the D-form, prepared as described in the
Materials and Methods section (17), were diluted with the
standard buffer pH 8.0 to 2.5 mg/ml and treated with 1 mM
H2O2 at 20. Aliquots were taken during incubation and the
activity was assayed. (C) Dose dependence of the inhibition
of NADH-oxidase activity of the D-form by H2O2. Mem-
branes (20lg/ml) were incubated for 1 h at 30C in the
presence of various concentration of H2O2 in the standard
buffer (pH = 8.0) supplemented with 6 mM 3-amino-1,2,4-
triazole, 15 lg/ml alamethicin, and 2 mM MgCl2. At the
end of the incubation period, 10lM NADH was added and
after activation, the reaction was started by addition of
150 lM NADH and 5lM cytochrome c. Values represent
mean– SEM for duplicate measurements in three experi-
ments. Q1, 2,3-dimethoxy-5-methyl-6-(3-methyl-2-butenyl)-
1,4-benzoquinone.
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complex I full activity could be restored after turnover-
dependent reactivation, the enzyme did not undergo signifi-
cant covalent modifications affecting its activity. It is therefore
likely that our chosen conditions of 20-min ischemia, with or
without 10-min reperfusion, were not sufficient to cause the
significant damage to complex I observed by others using a
longer ischemic treatment (23, 24). Nonetheless, complex I
catalyzed activities in mitochondria obtained from control,
ischemic, or reperfused samples in our experiments, is in
agreement with the findings of several other studies (51).
Oxidative stress is considered as an important mechanism
of I/R injury. Complex I-dependent production of ROS is
increased during reperfusion, although the underlying
mechanism remains unclear (2, 38, 43, 54). We have shown
that the complex I-dependent superoxide anion generation
was significantly higher in mitochondrial membranes isolated
from the ischemic heart, most likely, due to the presence of the
D-form accumulated during the ischemic period. This is in
agreement with the earlier observation of higher capacity for
superoxide generation by the D-form (20).
We also determined the sensitivity of the A- and the D-forms
of complex I to superoxide anion and hydrogen peroxide. In
heart mitochondrial membranes, exogenously added H2O2 in-
hibits only the D-form of the enzyme, but not the A-form. This
has been further tested on control samples and those obtained
20 min after ischemia, using a superoxide generating system able
to produce 0.25 nM/min superoxide. As expected, incubation of
mitochondrial membranes from the ischemic tissue in the pres-
ence of a low steady-state concentration of superoxide resulted
in a dramatic inhibition of the NADH-oxidase activity in com-
parison with control. Activation of complex I completely abol-
ished that inhibition, rendering the A-form of the enzyme less
sensitive to superoxide.
It is not clear what level of sensitivity of the enzyme to ROS
may be expected in situ, where the enzyme is exposed to ad-
ditional factors such as high osmolarity and electrical field,
and is surrounded by other proteins [including enzymes
mediating H2O2 oxidative action (21)]. Prolonged exposure of
the D-form of the enzyme to low steady-state levels of en-
dogenous ROS at physiological temperature would inevitably
result in irreversible damage to some fraction of the enzyme
population leading to accumulation of irreversibly modified
enzymes over time. Therefore, taking into account the high
degree of flux control of complex I over oxidative phosphor-
ylation (18, 26, 32), a slight decrease in the NADH:ubiquinone
reductase activity, even if this is not sufficient to induce an
acute effect on apparent respiration, may lead to a significant
decrease of the ATP production by mitochondria (52).
Together, our observations suggest that accumulation of the
D-form of the enzyme takes place during ischemia (i), this ac-
cumulation increases ROS production (ii); the presence of com-
plex I in the D-form may potentially increase susceptibility of
mitochondria to oxidative damage (iii), so could result in the so-
called vicious cycle of damage during I/R (5, 8, 14, 48).
The link between inhibition of complex I in I/R and the
nature of the oxidative modification of the enzyme is not
FIG. 5. Effect of H2O2 on the A- and D-form of mitochondrial complex I. Mitochondrial membranes were incubated with
H2O2 as explained in Figure 4 and then labeled with Cy3 (colored green) or Cy5 (colored red) SH-specific maleimide dyes and
complex I subunits were separated by 2D SDS gel as explained in Material and Methods. The superimposed images of both
fluorescent signals (A) and silver staining (B) of the same gel showing the labeled subunits. (C) Graph represent percentage of
intensity of numbered spots on the gels. Cy3-labeled spots are shown in green (representing A-sample) and Cy5-labeled
proteins are in red (representing D-sample). Results are given as the means – SD of the percentage intensity of spot from five
independent experiments, *p< 0.05.
Table 3. Proteins Involved in Oxidative Modification of the D-Form of Mitochondrial Complex I








1 ND4 P03911 51 882 1.942– 0.537 1/3a
2 B12 Q9CQZ6 11 692 2.183– 0.697 0/0
3 ND3 P03899 13 219 6.12 – 1.961 1/1a
aNumber of cysteins located in the interhelical region was determined from the high-resolution structure of prokaryotic complex I (9).
A/D, active/deactive.
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completely understood, but it is likely to involve oxidation,
nitrosation, nitration, glutathionylation, or disulfide forma-
tion of cysteine thiols (41). There have been a number of re-
ports on covalent modifications of complex I in I/R: thiol
oxidation of NDUFS1, NDUFS2, NDUFV1, NDUFV2, NDU-
FA6 (51), and tyrosine nitration of NDUFS2, NDUFS3, and
NDUFV2 (35) in the heart and nitration of GRIM-19 in brain
mitochondria (6). Our redox difference gel electrophoresis
(DIGE) results suggest three subunits that may be involved in
the functional modification of the D-form by H2O2: ND3, B12,
and ND4. However, the subunit B12 (NDUFB3) has no cys-
teine residues in its primary sequence and can therefore be
excluded. The highest difference in Cy-dye labeling of the
H2O2-treated A- and D-form makes ND3 the most likely
candidate. Moreover, identification of peptide, thiol labeled
by Cy-dye identifies cysteine-39 as the exact region of modi-
fication. This cysteine is exposed only in the D-form of the
enzyme as shown before (16). Most likely, if Cys-39 of the
ND3 subunit complex I is modified, the enzyme does not
catalyze the physiological NADH:ubiquinone reaction, mak-
ing it an early mitochondrial target for oxidative/nitrosative
stress during I/R.
Modification of the FeS clusters of complex I can be a major
factor for complex I inhibition (44, 50). In our experiments, the
possibility of FeS cluster damage cannot be excluded,
however, in vitro studies indicate that the accessibility of all
clusters to the outside environment is the same in the A- and
D-form (29).
The combined processes of accumulation of mitochondrial
fatty acid (27) and an increase in the matrix Mg2+ and Ca2+
concentration (11, 19, 47) would shift the A/D equilibrium of
complex I toward the D-form during an ischemic episode af-
fecting myocardial recovery. Moreover, after reoxygenation, the
possible opening of the mitochondrial permeability transition
pore could also result in Ca2+ overload (1, 7, 28, 40). Together
with the release of cytochrome c (4), this would significantly
delay complex I reactivation. At that stage, the exposure of Cys-
39 of the ND3 subunit of the D-form of complex I (16, 17) may be
an important factor determining specific inhibition of the
NADH:ubiquinone reductase activity by an as yet unknown
mechanism. As shown in our experimental settings, functional
modification of the D-form may give a rise to a population of
mitochondria with a decreased respiration rate, an over-reduced
pool of matrix NAD(P) nucleotides, and a low ATP-synthesizing
capacity. Such a population would delay or significantly retard
the functional recovery of the cardiomyocytes in I/R. Our results
suggest that the deactivation of mitochondrial complex I and
increased susceptibility of the enzyme to ROS or nitric oxide
metabolites (17) after the ischemic period may represent one of
the important contributory mechanisms involved in cardiac in-
jury during acute I/R. Combined classical therapy and inter-
ventions for fine tuning of the A/D ratio in mitochondria during




Female C57BL/6J mice (8–12 weeks, Charles River) were
employed for all studies and were fasted overnight before
experimentation. Animals were housed under constant
climatic conditions with free access to food and water. All
experiments were performed in accordance with the Gui-
dance on the Operation of the Animals (Scientific Procedures)
Act, 1986 (UK).
Cardiac arrest and tissue extraction
Cardiac and respiratory arrest was initiated by cervical
dislocation, carcasses were placed in a portable 37C incuba-
tor to maintain physiological body temperature. After specific
time periods (2–30 min), organs or tissues were rapidly
(within 90 s) extracted, washed in an ice-cold phosphate saline
buffer, and snap-frozen in liquid nitrogen.
In vivo ischemia reperfusion
Mice were subjected to acute myocardial ischemia by li-
gation of the left anterior descending coronary artery under
2% isofluorane/oxygen anesthesia as previously described
(36). This procedure has been shown to produce reliable and
reproducible myocardial infarcts of *40%. Animals were
sacrificed by cervical dislocation either after 20 min of ische-
mia or after a further 10-min period of reperfusion. Hearts
were then rapidly excised and separated into ischemic or
nonischemic regions (control) before being frozen in liquid
nitrogen and stored at - 80C for further analysis.
Mitochondrial membrane isolation
Isolation of the mitochondrial membranes preserving of the
A/D ratio was performed essentially as previously described,
with minor modifications (39). Pieces of frozen tissue were
then placed in a liquid nitrogen precooled metal mortar and
pulverized by striking with a mallet. The resulting powder
was added to 10 ml of the isolation medium (200 mM
Tris-HCl, pH 8.8, 0.5 mM EDTA 1 mM K3Fe(CN)6, and 2 mM
potassium malonate) and homogenized in a IKA tissue dis-
ruptor (2 min· 6000 rpm). Particular care was taken to cool
down all the mediums, glassware, and centrifuge rotors. An
alkaline buffer and 1 mM ferricyanide were used to allow
rapid oxidation of reduced matrix pyridine nucleotides to
prevent turnover-dependent complex I activation. Tissue
debris was discarded after brief centrifugation for 10 min at
16,000 g at 0C. The supernatant was diluted to 40 ml with the
same medium and the membranes were collected by centri-
fugation for 25 min at 48,000 g. The membrane pellet was
rinsed with 20 mM Tris-HCl (pH 8.0), 0.25 M sucrose, and
0.2 mM EDTA and resuspended in 400ll of the same buffer.
The membranes were then frozen in liquid nitrogen and
stored at - 80C until use. The protein content was deter-
mined by bicinchoninic acid (BCA) assay (Sigma).
Activity measurements
Oxidation of NADH was determined spectrophotometri-
cally (Varian Cary 4000) as a decrease in absorption at 340 nm
with 150lM NADH in 1 ml of the standard assay medium
(0.25 M sucrose, 50 mM Tris-HCl pH 7.0, 0.2 mM EDTA)
supplemented with 5 lM cytochrome c and containing 10–
25lg protein/ml mitochondrial membranes. Additional
measurements of NADH:Q1 or NADH:HAR oxidoreductase
reductase were assayed in the presence of 1 mM cyanide with
the addition of 80 lM Q1 or 1 mM HAR, respectively (Sigma).
The formation of superoxide radicals was monitored as
the SOD-sensitive reduction of acetylated cytochrome
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c [e550–539nm = 21.5, (15)] in the same assay medium, pH 8.0,
supplemented with 20lM acetylated cytochrome c, substrates
(50 lM NADH or 5 mM succinate) and containing 0.4–
0.5 mg/ml mitochondrial membranes. Acetylated cyto-
chrome c was prepared as described previously (15).
Determination of A/D ratio. The diagnostic test for deter-
mination of the A/D ratio is based on the fact that in the
presence of divalent cations such as Mg + + or Ca + + and at
alkaline pH (8.5), the rate of reactivation of complex I is very
slow (39) (see also (30) for the details). The total amount of the
enzyme (A +D) was estimated after full activation of complex
I by preincubation of the sample in 0.1 ml of a standard me-
dium (pH 7.0) with 20 lM NADH for 30 s before the addition
of 0.9 ml of the standard medium (pH 8.8), 5.5 mMMgCl2, and
165 lM NADH. For estimation of the A-form fraction, 20lM
NADH was omitted from the initial preincubation in the pH
7.0 medium. In these conditions, the initial rate of NADH-
oxidase accurately corresponds to the activity contributed
only by the A-form, since the activation of the D-form is sig-
nificantly slower than the time of the assay. In all inhibition
studies, the D-form was treated with an effector and activity
assessed only after activation by NADH.
To prepare SMP in which complex I is present almost entirely
in the D-form, an aliquot of frozen membranes was thawed,
diluted to 5 mg/ml with a standard assay medium (pH 8.5), and
incubated at 35 C for 1 h. To obtain a fully active enzyme, after
thermal deactivation, membranes were incubated aerobically for
10–20 min at room temperature with 1% ethanol, 400lM
NADH, and 0.1 mg/ml alcohol dehydrogenase (17).
Redox DIGE and subunits identification
Redox DIGE was performed essentially as previously
published (25). Control and membranes treated with 1 mM
H2O2 were washed by centrifugation, 20 mM NEM was ad-
ded to the suspension, incubated at 30C for 30 min, and
membranes were washed once with the standard buffer. After
resuspending the pellet at around 1 mg/ml, 5 mM dithio-
threitol (DTT) was added and samples were incubated at 10C
for 15 min. Membranes were pelleted by centrifugation and
washed three times with the same buffer, resuspended at
1 mg/ml, and treated with 30lM Cy3- or Cy5-maleimide.
Each sample was treated with both dyes. After 30 min, the
reaction was quenched with 10 mM DTT and washed twice
before pooling of labeled samples.
Complex I subunits were separated as described previously
(16). The gels were scanned using the Fujifilm FLA fluorescent
scanner and stained with silver (49). Images were quantita-
tively analyzed using Aida Image Analyzer software (Rayt-
est).
Spots of interest were excised, the proteins in-gel digested,
and identification was performed through mass spectrometric
analysis at the BSRC Mass Spectrometry and Proteomics Fa-
cility, University of St Andrews (See Supplementary Data).
All proteins were identified with > 99% confidence (Prot
Score > 2.0) with False Discovery Rates of Local FDR < 5%,
Global FDR < 1%.
Statistical analysis
All results are expressed as mean– SEM unless specifically
indicated and were analyzed by one-way ANOVA to deter-
mine statistically significant differences of means among
groups.
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